Primary Site >> Liver Cancer

Gene >> RASAL1

Journal: Invest New Drugs. 2010 Apr;28(2):107-14.
Title: The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines.
Author: Ma, Brigette B Y|Sung, Fion|Tao, Qian|Poon, Fan Fong|Lui, Vivian W|Yeo, Winnie|Chan, Stephen L|Chan, Anthony T C
PMID: 19172229
Journal: J Hepatol. 2011 Feb;54(2):311-9.
Title: Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer.
Author: Calvisi, Diego F|Ladu, Sara|Conner, Elizabeth A|Seo, Daekwan|Hsieh, Jer-Tsong|Factor, Valentina M|Thorgeirsson, Snorri S
PMID: 21067840
Journal: Oncol Rep. 2017 Jan;37(1):273-280.
Title: Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1.
Author: Jin, Weidong|Chen, Lei|Cai, Xun|Zhang, Yunxiao|Zhang, Jianxin|Ma, Dangdang|Cai, Xiong|Fu, Tao|Yu, Zhengping|Yu, Fuxiang|Chen, Gang
PMID: 27878301
Journal: Oncol Lett. 2017 Dec;14(6):7344-7352.
Title: RASAL1 inhibits HepG2 cell growth via HIF-2alpha mediated gluconeogenesis.
Author: Meng, Fanhua|Zhang, Wei|Wang, Yufeng
PMID: 29344173